Thomson H, Fong W, Stafford W, Frenneaux M
Division of Medicine, Royal Brisbane Hospital, Herston, Queensland, Australia.
Br Heart J. 1995 Sep;74(3):220-3. doi: 10.1136/hrt.74.3.220.
Atypical and typical chest pains are common symptoms in patients with hypertrophic cardiomyopathy. Some of these chest pains seem to be caused by ischaemia. It is difficult to objectively demonstrate ischaemia in hypertrophic cardiomyopathy. The first line treatment for chest pain considered to be ischaemic in patients with hypertrophic cardiomyopathy is the use of either a beta blocker or calcium blocker. Septal myectomy can be effective in patients with symptoms refractory to conventional treatment but is associated with significant morbidity and mortality. Recently dual chamber pacing has been advocated in such patients. In some cases dual chamber pacing alleviates chest pain in hypertrophic cardiomyopathy by an anti-ischaemic action, presumably by reducing the left ventricular outflow tract gradient and perhaps by causing an associated decrease in left ventricular outflow tract gradient and perhaps by causing an associated decrease in left ventricular end diastolic pressure.
非典型和典型胸痛是肥厚型心肌病患者的常见症状。其中一些胸痛似乎由缺血引起。在肥厚型心肌病中,很难客观地证明存在缺血。对于肥厚型心肌病患者中被认为是缺血性胸痛的一线治疗方法是使用β受体阻滞剂或钙通道阻滞剂。对于常规治疗无效的症状性患者,室间隔心肌切除术可能有效,但会伴有显著的发病率和死亡率。最近,有人主张对这类患者进行双腔起搏治疗。在某些情况下,双腔起搏通过抗缺血作用缓解肥厚型心肌病患者的胸痛,推测是通过降低左心室流出道压力阶差,或许还通过使左心室舒张末期压力相应降低来实现的。